Tagged covance

Drug-Drug Interactions: Understanding Proposed FDA Regulatory Updates and Applying In Vitro and Physiologically Based Techniques
Press Release

Drug-Drug Interactions: Understanding Proposed FDA Regulatory Updates and Applying In Vitro and Physiologically Based Techniques

 Read More
Drug Abuse Potential: A Data Analysis Strategy for Nonclinical Self-Administration Studies, New Webinar Hosted by Xtalks
Press Release

Drug Abuse Potential: A Data Analysis Strategy for Nonclinical Self-Administration Studies, New Webinar Hosted by Xtalks

 Read More
Sugar Reduction in Beverages - 4 Key Challenges and How to Tackle Them, New Webinar Hosted by Xtalks
Press Release

Sugar Reduction in Beverages - 4 Key Challenges and How to Tackle Them, New Webinar Hosted by Xtalks

 Read More
On the Spot: Multiplex FluoroSpot-Based Testing in Clinical Evaluation of Vaccines and Novel Immunotherapeutics, New Webinar Hosted by Xtalks
Press Release

On the Spot: Multiplex FluoroSpot-Based Testing in Clinical Evaluation of Vaccines and Novel Immunotherapeutics, New Webinar Hosted by Xtalks

 Read More
New Xtalks Webinar to Address the Increasing Demand for Single-Site Pre-Market Approval Models in the Pursuit of Companion Diagnostic Development (CDx)
Press Release

New Xtalks Webinar to Address the Increasing Demand for Single-Site Pre-Market Approval Models in the Pursuit of Companion Diagnostic Development (CDx)

Flexible, Fast, Efficient: The Expanding Role of Single-Site PMA Approval in Companion Diagnostics Development

 Read More
Leveraging Key Biomarkers to Advance Immuno-Oncology Drug Development and Find the Right Trial Participants, New Webinar Hosted by Xtalks
Press Release

Leveraging Key Biomarkers to Advance Immuno-Oncology Drug Development and Find the Right Trial Participants, New Webinar Hosted by Xtalks

Presented by Covance Chief Scientific Officer Steve Anderson, Ph.D., and Covance Global Leader, Precision Medicine and Head, Biomarker Solution Center, Suso Platero, Ph.D., this webinar will address the spectrum of immunotherapy development considerations and their implications for drug developers.

 Read More
Vaccine Development Strategies for Stubborn Diseases: Battling the Measles and Mumps Comeback, New Webinar Hosted by Xtalks
Press Release

Vaccine Development Strategies for Stubborn Diseases: Battling the Measles and Mumps Comeback, New Webinar Hosted by Xtalks

 Read More
Press Release

Auxiliis Partners With KinderPharm LLC to Provide Global Access for Paediatric Drug Development and Patients

By bridging the strengths of both Auxiliis and KinderPharm complement their overall clinical trials for paediatric capabilities.

 Read More